AGO-OVAR23/DUO-O
Trial Description:
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Follow Up
Contact person:
pharter